Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/9256141

Download in:

View as

General Info

PMID
9256141